Hydrofarm (HYFM) director Melisa Denis receives 30,000 RSU equity award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
HYDROFARM HOLDINGS GROUP, INC. director Melisa Denis reported an equity compensation grant. Denis acquired 30,000 shares of common stock in the form of restricted stock units under the company’s 2020 Equity Incentive Plan, at a stated price of $0.00 per share.
The 30,000 restricted stock units are scheduled to vest on June 23, 2027, meaning they will deliver shares only if the vesting conditions are met and Denis remains eligible. Following this award, Denis directly holds 88,423 shares of Hydrofarm common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Denis Melisa
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.0001 par value per share | 30,000 | $0.00 | -- |
Holdings After Transaction:
Common Stock, $0.0001 par value per share — 88,423 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
RSU grant: 30,000 shares
Grant price: $0.00 per share
Post-grant holdings: 88,423 shares
+1 more
4 metrics
RSU grant
30,000 shares
Restricted stock units granted as equity award
Grant price
$0.00 per share
Stated transaction price for RSU grant
Post-grant holdings
88,423 shares
Total common shares held directly after transaction
Vesting date
June 23, 2027
Scheduled vesting of 30,000 restricted stock units
Key Terms
restricted stock units, 2020 Equity Incentive Plan, Form 4, transaction code "A"
4 terms
restricted stock units financial
"Includes 30,000 restricted stock units granted under the Issuer's 2020 Equity Incentive Plan which will vest on June 23, 2027."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2020 Equity Incentive Plan financial
"Includes 30,000 restricted stock units granted under the Issuer's 2020 Equity Incentive Plan which will vest on June 23, 2027."
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
transaction code "A" financial
"transaction_code": "A","transaction_code_description": "Grant, award, or other acquisition""
FAQ
What insider transaction did HYFM director Melisa Denis report on this Form 4?
Melisa Denis reported receiving 30,000 restricted stock units of HYDROFARM common stock as an equity award. The grant was made at a stated price of $0.00 per share under the company’s 2020 Equity Incentive Plan as part of director compensation.
When do Melisa Denis’s 30,000 Hydrofarm (HYFM) restricted stock units vest?
The 30,000 restricted stock units granted to Melisa Denis are scheduled to vest on June 23, 2027. Vesting means the units convert into shares if the conditions are met, typically requiring continued service through the vesting date.
Was Melisa Denis’s HYFM Form 4 transaction a market purchase or a compensation award?
The Form 4 shows a compensation award, not a market purchase. The transaction code is “A” for grant or award, and the 30,000 restricted stock units were issued at a stated price of $0.00 per share under Hydrofarm’s 2020 Equity Incentive Plan.
What is the significance of the 2020 Equity Incentive Plan for HYFM in this filing?
The 2020 Equity Incentive Plan is the program under which Hydrofarm granted 30,000 restricted stock units to director Melisa Denis. It governs equity-based compensation, including vesting terms, and is used to align director and employee interests with long-term shareholder value.